DK3580567T3 - I vitro-fremgangsmåde til diagnose af lungkræft - Google Patents

I vitro-fremgangsmåde til diagnose af lungkræft Download PDF

Info

Publication number
DK3580567T3
DK3580567T3 DK18703784.1T DK18703784T DK3580567T3 DK 3580567 T3 DK3580567 T3 DK 3580567T3 DK 18703784 T DK18703784 T DK 18703784T DK 3580567 T3 DK3580567 T3 DK 3580567T3
Authority
DK
Denmark
Prior art keywords
diagnosis
lung cancer
vitro procedure
vitro
procedure
Prior art date
Application number
DK18703784.1T
Other languages
English (en)
Inventor
Arrazubi Jackeline Agorreta
Martínez-Polo Daniel Ajona
Badia Luís Montuenga
Villandiego María Josefa Pajares
Osés Rubén Pío
Original Assignee
Fundacion Para La Investig Medica Aplicada
Advanced Marker Discovery S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Para La Investig Medica Aplicada, Advanced Marker Discovery S L filed Critical Fundacion Para La Investig Medica Aplicada
Application granted granted Critical
Publication of DK3580567T3 publication Critical patent/DK3580567T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK18703784.1T 2017-02-08 2018-02-08 I vitro-fremgangsmåde til diagnose af lungkræft DK3580567T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382054.9A EP3361256A1 (en) 2017-02-08 2017-02-08 In vitro method for the diagnosis of lung cancer
PCT/EP2018/053234 WO2018146232A1 (en) 2017-02-08 2018-02-08 In vitro method for the diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
DK3580567T3 true DK3580567T3 (da) 2021-07-12

Family

ID=58043996

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18703784.1T DK3580567T3 (da) 2017-02-08 2018-02-08 I vitro-fremgangsmåde til diagnose af lungkræft

Country Status (11)

Country Link
US (1) US20200025765A1 (da)
EP (2) EP3361256A1 (da)
CN (1) CN110770584B (da)
AU (1) AU2018217372B2 (da)
CA (1) CA3052529A1 (da)
DK (1) DK3580567T3 (da)
ES (1) ES2880761T3 (da)
HU (1) HUE054864T2 (da)
PL (1) PL3580567T3 (da)
PT (1) PT3580567T (da)
WO (1) WO2018146232A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023513470A (ja) 2020-01-30 2023-03-31 プログノミック インコーポレイテッド 肺バイオマーカーおよびそれらの使用方法
CA3163498A1 (en) * 2020-10-02 2022-04-07 Board Of Regents, The University Of Texas System Methods for the detection and treatment of lung cancer
GB2607436A (en) * 2021-03-31 2022-12-07 Prognomiq Inc Multi-omic assessment
AU2022341187A1 (en) 2021-09-13 2024-03-21 PrognomIQ, Inc. Enhanced detection and quantitation of biomolecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007501948A (ja) * 2003-06-13 2007-02-01 ユニバーシティー オブ ピッツバーグ 免疫疾患、血液疾患および炎症性疾患のモニタリング
EP2788478B1 (en) * 2011-12-09 2017-08-23 Institut Pasteur Multiplex immuno screening assay
AU2012358246B2 (en) * 2011-12-21 2018-01-25 Integrated Diagnostics, Inc. Methods for diagnosis of lung cancer
ES2670661T3 (es) * 2012-03-29 2018-05-31 Proyecto De Biomedicina Cima, S.L. Nuevos marcadores moleculares de cáncer de pulmón

Also Published As

Publication number Publication date
CA3052529A1 (en) 2018-08-16
WO2018146232A1 (en) 2018-08-16
CN110770584B (zh) 2023-06-13
AU2018217372B2 (en) 2024-01-25
US20200025765A1 (en) 2020-01-23
EP3580567B1 (en) 2021-04-07
PL3580567T3 (pl) 2021-12-06
PT3580567T (pt) 2021-07-14
EP3361256A1 (en) 2018-08-15
CN110770584A (zh) 2020-02-07
AU2018217372A1 (en) 2019-09-12
ES2880761T3 (es) 2021-11-25
HUE054864T2 (hu) 2021-10-28
EP3580567A1 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
DK3189082T3 (da) Anti-pd-l1-konjugater til behandling af tumorer
DK3697887T3 (da) Perfusionsfremgangsmåder
DK3474841T3 (da) Fremgangsmåder til behandling af ar+-brystkræft
BR112016030398A2 (pt) Instrumento cirúrgico endoscópico
DK3151663T3 (da) Ex vivo-organplejesystem
MA42238A (fr) Procédés de diagnostic du cancer de la vessie
DK3166976T3 (da) Anti-pd-l1-kombinationer til behandling af tumorer
DE112015002825A5 (de) Nicht-invasive Stoffanalyse
DK3302502T3 (da) Intrapulmonal administration af polynukleotid-agonister af toll-lignende receptor-9 til behandling af lungecancer
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3474804T3 (da) Medicinsk forbinding
EP3307243A4 (en) Diagnostic test for early stage cancer
DK3117030T3 (da) Diagnosticering af sepsis
DK3123381T3 (da) Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
DK3467111T3 (da) LNCRNAS til terapi og diagnose af hjertehypertrofi
DK3560937T3 (da) Fremgangsmåder til fremstilling af 18f-mærkede psma-målrettede billeddannelsesmidler og diagnostiske fremgangsmåder dermed
HK1248803A1 (zh) 用於肝癌的無創診斷的特異性生物標誌物組
DK3580567T3 (da) I vitro-fremgangsmåde til diagnose af lungkræft
DK3058374T3 (da) Fremgangsmåde til diagnose af primær hyperaldosteronisme
DK3461806T3 (da) Fremgangsmåde til fremstilling af alfa-hydroxymethionin-analoger ud fra sukker
DE112015000447A5 (de) Positionierhilfe für chirurgische Eingriffe
DK3452795T3 (da) Inspektionsfremgangsmåde
SG10201913528PA (en) Methods of diagnosing cancer
DK3474803T3 (da) Medicinsk forbinding
DK3592297T3 (da) Vævsteknologistilladser